Generalized lymphatic anomalies and review of the current management landscape: a case report and review of the literature.
Case report
Diffuse systemic lymphangiomatosis
Generalized lymphatic anomalies
Generalized vascular anomalies
Lymphangioma
Lymphatic malformations
Multisystemic lymphangiomatosis
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
10 Aug 2021
10 Aug 2021
Historique:
received:
14
07
2020
accepted:
09
06
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
12
8
2021
Statut:
epublish
Résumé
Generalized lymphatic anomaly previously known as diffuse systemic lymphangiomatosis is a rare multisystem congenital disease arising from the lymphatic system, and it is characterized by abnormal proliferation of the lymphatic channels in osseous and extraosseous tissues. It typically affects children or young adults. Although it is benign, it can be misdiagnosed as malignancy because of its diffuse and debilitating nature depending on the site of involvement. Due to its rarity, diagnosis is often delayed, leading to potential significant morbidity or mortality if vital organs are involved. Furthermore, its potential for multiorgan involvement with no curative treatment makes its management challenging. We describe a case of a 35-year-old Caucasian female, who presented with epigastric pain and was subsequently extensively investigated at multiple tertiary centers by numerous specialists for query malignancy and metabolic bone disorder following incidental computed tomography imaging findings of multiple osteolytic lesions in the axial skeleton, and low-attenuating lesions in the axilla, spleen, and mediastinum. The diagnosis was confirmed with an axillary excisional biopsy. She was clinically stable with no end organ damage. She was monitored conservatively. The case illustrates the importance of increased awareness among clinicians for this rare congenital disease to enable earlier diagnosis and to avoid unnecessary invasive investigations. Furthermore, this case highlights the potential need for multiple biopsies of affected sites to confirm diagnosis. We also discuss the emergence of interferon therapy, chemotherapy, immunosuppression, and immunotherapy as medical management for this condition.
Sections du résumé
BACKGROUND
BACKGROUND
Generalized lymphatic anomaly previously known as diffuse systemic lymphangiomatosis is a rare multisystem congenital disease arising from the lymphatic system, and it is characterized by abnormal proliferation of the lymphatic channels in osseous and extraosseous tissues. It typically affects children or young adults. Although it is benign, it can be misdiagnosed as malignancy because of its diffuse and debilitating nature depending on the site of involvement. Due to its rarity, diagnosis is often delayed, leading to potential significant morbidity or mortality if vital organs are involved. Furthermore, its potential for multiorgan involvement with no curative treatment makes its management challenging.
CASE PRESENTATION
METHODS
We describe a case of a 35-year-old Caucasian female, who presented with epigastric pain and was subsequently extensively investigated at multiple tertiary centers by numerous specialists for query malignancy and metabolic bone disorder following incidental computed tomography imaging findings of multiple osteolytic lesions in the axial skeleton, and low-attenuating lesions in the axilla, spleen, and mediastinum. The diagnosis was confirmed with an axillary excisional biopsy. She was clinically stable with no end organ damage. She was monitored conservatively.
CONCLUSIONS
CONCLUSIONS
The case illustrates the importance of increased awareness among clinicians for this rare congenital disease to enable earlier diagnosis and to avoid unnecessary invasive investigations. Furthermore, this case highlights the potential need for multiple biopsies of affected sites to confirm diagnosis. We also discuss the emergence of interferon therapy, chemotherapy, immunosuppression, and immunotherapy as medical management for this condition.
Identifiants
pubmed: 34372919
doi: 10.1186/s13256-021-02953-9
pii: 10.1186/s13256-021-02953-9
pmc: PMC8353871
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
398Informations de copyright
© 2021. The Author(s).
Références
J Pediatr Hematol Oncol. 2015 Nov;37(8):e481-5
pubmed: 26458155
Semin Pediatr Surg. 2014 Aug;23(4):178-85
pubmed: 25241095
J Pediatr Hematol Oncol. 2004 Feb;26(2):136-41
pubmed: 14767208
Facial Plast Surg. 2016 Apr;32(2):162-76
pubmed: 27097138
Pediatr Pulmonol. 2000 Apr;29(4):321-4
pubmed: 10738021
Lymphat Res Biol. 2011;9(4):191-3
pubmed: 22196284
Clin Radiol. 2012 Aug;67(8):782-8
pubmed: 22424931
Acta Cytol. 2009 Mar-Apr;53(2):191-4
pubmed: 19365974
Hematol Oncol Clin North Am. 2019 Jun;33(3):455-470
pubmed: 31030813
AJR Am J Roentgenol. 2004 Apr;182(4):1068
pubmed: 15039189
J Pediatr Surg. 2013 Mar;48(3):e9-12
pubmed: 23480949
N Engl J Med. 1980 Jul 31;303(5):270-6
pubmed: 7383110
Pediatr Hematol Oncol. 2007 Oct-Nov;24(7):513-24
pubmed: 17786787
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):1037-46
pubmed: 10712360
World J Gastroenterol. 2014 Jul 7;20(25):8320-4
pubmed: 25009412
Pediatr Blood Cancer. 2007 Jan;48(1):108-11
pubmed: 16007599
JAMA Otolaryngol Head Neck Surg. 2014 Jan;140(1):41-5
pubmed: 24288004
Clin Imaging. 2013 Jul-Aug;37(4):723-7
pubmed: 23391872
Pediatr Dermatol. 2018 Jul;35(4):533-534
pubmed: 29582448
Ann Intern Med. 2012 Jun 5;156(11):839-40
pubmed: 22665821
Skeletal Radiol. 1993 Aug;22(6):464-7
pubmed: 8248825
J Natl Compr Canc Netw. 2016 Apr;14(4):383-6
pubmed: 27059187
Pediatr Blood Cancer. 2011 Apr;56(4):667-70
pubmed: 21298758
Pediatr Blood Cancer. 2019 May;66(5):e27614
pubmed: 30672136
Ann Oncol. 2010 Aug;21(8):1733-1734
pubmed: 20605931
BMJ Case Rep. 2018 Apr 5;2018:
pubmed: 29622712
J Korean Med Sci. 2010 Jan;25(1):155-8
pubmed: 20052363
Respirol Case Rep. 2018 Nov 28;7(1):e00384
pubmed: 30510764
Pediatrics. 2016 Feb;137(2):e20153257
pubmed: 26783326
Pediatrics. 2015 Jul;136(1):e203-14
pubmed: 26055853
Respir Med Case Rep. 2020 Feb 01;29:101014
pubmed: 32071853